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Abstract
Background: Chloride (Cl) secretion by the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) located in the
apical membrane of respiratory epithelial cells plays a critical role in maintenance of the airway surface liquid and
mucociliary clearance of pathogens. Previously, we and others have shown that the serum and glucocorticoid-inducible
kinase-1 (SGK1) increases wild type CFTR (wt-CFTR) mediated Cl transport in Xenopus oocytes by increasing the amount of
wt-CFTR protein in the plasma membrane. However, the effect of SGK1 on the membrane abundance of wt-CFTR in airway
epithelial cells has not been examined, and the mechanism whereby SGK1 increases membrane wt-CFTR has also not been
examined. Thus, the goal of this study was to elucidate the mechanism whereby SGK1 regulates the membrane abundance
of wt-CFTR in human airway epithelial cells.
Methods and Results: We report that elevated levels of SGK1, induced by dexamethasone, increase plasma membrane
abundance of wt-CFTR. Reduction of SGK1 expression by siRNA (siSGK1) and inhibition of SGK1 activity by the SGK inhibitor
GSK 650394 abrogated the ability of dexamethasone to increase plasma membrane wt-CFTR. Overexpression of a
constitutively active SGK1 (SGK1-S422D) increased plasma membrane abundance of wt-CFTR. To understand the
mechanism whereby SGK1 increased plasma membrane wt-CFTR, we examined the effects of siSGK1 and SGK1-S442D on
the endocytic retrieval of wt-CFTR. While siSGK1 increased wt-CFTR endocytosis, SGK1-S442D inhibited CFTR endocytosis.
Neither siSGK1 nor SGK1-S442D altered the recycling of endocytosed wt-CFTR back to the plasma membrane. By contrast,
SGK1 increased the endocytosis of the epidermal growth factor receptor (EGFR).
Conclusion: This study demonstrates for the first time that SGK1 selectively increases wt-CFTR in the plasma membrane of
human airway epithelia cells by inhibiting its endocytic retrieval from the membrane.
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Introduction
The Cystic Fibrosis Transmembrane Conductance Regulator
(CFTR) is a cyclic-AMP regulated chloride (Cl) channel residing in
the apical plasma membrane of a variety of epithelial cells,
including those in the lungs [1]. Cl secretion via wt-CFTR is
critical in maintaining the airway surface liquid volume, and
therefore, is essential for effective mucociliary clearance, which
mechanically clears debris and pathogens from the airways and
serves a vital role in innate immunity [2]. Individuals with
defective CFTR function, for example patients with Cystic Fibrosis
or chronic smokers, have chronic lung infections due to a lack of
clearance of respiratory pathogens [2,3]. wt-CFTR function and
localization in the cell are highly regulated by a complex of
proteins that modulates its biosynthesis, trafficking to and from the
plasma membrane, and channel activity [1,4–7]. Once delivered
to the apical plasma membrane of airway epithelial cells, wt-
CFTR is rapidly endocytosed from the plasma membrane and
then undergoes rapid and efficient recycling back to the plasma
membrane [1,8–11]. We and others have demonstrated that the
endocytic trafficking of wt-CFTR is regulated by numerous
protein-protein interactions, as well as by ubiquitination [1,4–
7,12].
SGK1 is transcriptionally regulated by a variety of stimuli
including stress, serum, and a large number of cytokines and
hormones including gluococorticoids [13]. SGK1 regulates a
number of ion channels including ENaC, CFTR, and ROMK
that play important roles in sodium and potassium excretion by
the kidneys, as well as in the maintenance of airway surface liquid
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volume in the lungs [5,13]. A variant of SGK1 is associated with
increased blood pressure, obesity and type II diabetes [13].
Previously, others and we have shown that SGK1 stimulates wt-
CFTR mediated chloride (Cl) currents in Xenopus oocytes by
increasing the amount of wt-CFTR protein in the plasma
membrane [14,15]. Moreover, SGK1 also increases the plasma
membrane abundance of wt-CFTR in the plasma membrane of
mitochondrion rich cells in the gill of Fundulus heteroclitus [16,17]. In
a recent study Caohuy et al [18] demonstrated that dexametha-
sone increases the plasma membrane expression of both wt-CFTR
and DF508-CFTR in pancreatic cells, and that RNA interference
of SGK1 blocks the stimulatory effect of dexamethasone on
plasma membrane DF508-CFTR, a finding suggesting that SGK1
increases plasma membrane CFTR. In addition, two recent
studies [19,20] have shown that dexamethasone increases wt-
CFTR abundance in airway cell lines. However, the mechanism
whereby SGK1 increased the plasma membrane abundance of wt-
CFTR has not been examined. Thus, the primary goal of this
study was to elucidate the cellular mechanism whereby SGK1
increases plasma membrane wt-CFTR. The data herein is novel
because it demonstrates that SGK1 selectively increases wt-CFTR
in the plasma membrane of human airway epithelial cells by
inhibiting its endocytic retrieval from the membrane.
Materials and Methods
Cell Culture
The role of SGK1 in regulating plasma membrane wt-CFTR
was studied in human airway epithelial cells (CFBE41o- cells,
homozygous for the DF508 mutation) stably expressing wt-CFTR,
(generously provided by Dr. J.P. Clancy, University of Cincin-
nati)[21]. Details on the stable transfection and characterization of
CFBE41o- cells expressing wt-CFTR (hereafter called CFBE cells)
have been described in detail previously [10,11]. Cells between
passages 18 and 27 were grown in an air-liquid interface culture at
37uC [10,11]. To establish confluent, polarized monolayers,
16106 cells were seeded onto 24-mm Transwell permeable
supports (0.4-mm pore size, Corning, Corning, NY) coated with
Vitrogen plating medium containing human fibronectin (10 mg/
ml, Collaborative Biomedical Products, Bedford, MA), PureCol
(1%, Inamed Biomaterials, Fremont, CA), and bovine serum
albumin (10 mg/ml, Invitrogen) and grown in an air-liquid
interface culture at 37uC for 6–9 days, as described [10,11].
RNA-mediated Interference
SGK1 expression was selectively reduced using siRNA
purchased from Qiagen (Valencia, CA), using methods described
previously [11]. Sequences for siSGK1 are: sense 59 CAG CUG
AAA UGU ACG ACA A 39; antisense 59 UUG UCG UAC AUU
UCA GCU G 39; and siNegative scrambled sense 59 UUC UCC
GAA CGU GUC ACG U 39 and antisense 59 ACG UGA CAC
GUU CGG AGA A 39.
Biochemical Determination of the Apical Membrane wt-
CFTR
The biochemical determination of apical membrane wt-CFTR
was performed by domain selective cell membrane protein
biotinylation using EZ-LinkTM Sulfo-NHS-LC-Biotin (Pierce), as
described previously in detail [22].
wt-CFTR Endocytic and Recycling Assays
wt-CFTR and EGFR endocytosis and wt-CFTR recycling were
measured in polarized monolayers of cells using a cell membrane
protein biotinylation approach as described in detail by our
laboratory [22]. In brief, for both assays, plasma membrane
proteins were biotinylated at 4uC using EZ-LinkTM Sulfo-NHS-
SS-Biotin (Thermo Scientific Rockford, IL). For the endocytic
assay, cells were then warmed to 37uC for 5 minutes, and then
GSH was added at 4uC to reduce the disulfide bonds between
proteins labeled with Sulfo-NHS-SS-Biotin in the plasma mem-
brane. Biotinylated proteins that were endocytosed during the 5-
minute period at 37uC are not reduced by GSH, which is
impermeant to the plasma membrane, and therefore at this time in
the protocol biotinylated proteins are only in endosomes.
Thereafter, cells were lysed, and biotinylated proteins were
isolated using streptavidin-agarose beads, eluted into SDS sample
buffer, separated by 7.5% SDS-PAGE, and wt-CFTR and EGFR
were detected by Western blot. The amount of biotinylated wt-
CFTR and EGFR remaining in the plasma membrane after GSH
treatment at 4uC and without the 37uC warming was considered
background (,5% compared with the amount of biotinylated wt-
CFTR and EGFR at 4uC without GSH treatment) and was
subtracted from biotinylated wt-CFTR and EGFR after warming
to 37uC. wt-CFTR and EGFR endocytosis were calculated after
subtraction of the background and expressed as the percentage of
biotinylated wt-CFTR and EGFR after warming to 37uC
compared with the amount of biotinylated wt-CFTR and EGFR
present before warming to 37uC (minus background). For the wt-
CFTR endocytic recycling assay, cells were warmed to 37uC for 5
minutes after biotinylation to load endocytic vesicles with
biotinylated proteins. Cells were then cooled to 4uC, and the
disulfide bonds on Sulfo-NHS-SS-Biotin-labeled proteins remain-
ing in the plasma membrane were reduced by GSH at 4uC.
Subsequently, cells were either lysed (to detect the amount of wt-
CFTR in endosomes) or warmed again to 37uC for 5 minutes (to
allow biotinylated wt-CFTR to recycle from endosomes back to
the plasma membrane). Cells were then cooled again to 4uC, and
the disulfide bonds on the proteins bound to Sulfo-NHS-SS-Biotin
remaining in the plasma membrane were reduced with GSH. The
recycling of endocytosed wt-CFTR from endosomes to the apical
plasma membrane was calculated as the difference between the
amount of biotinylated wt-CFTR after the first and second GSH
treatments.Figure 1. Dexamethasone increased SGK1 mRNA expression in
CFBE cells. Dexamethasone (50 nM for 30 minutes) increased SGK1
mRNA versus control, as determined by Q-RT-PCR. Experiments
performed three times. *p,0.05.
doi:10.1371/journal.pone.0089599.g001
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Western Blot Analysis
Western blot analysis of SGK1, wt-CFTR, ezrin, EEA1, Rab5a,
Rab11a and EGFR were conducted by methods described
previously [4,22].
Intracellular Vesicle Isolation
To examine the effect of SGK1 on the endosomal trafficking of
wt-CFTR, differential centrifugation combined with immunopre-
cipitation techniques were used to isolate early and recycling
endosomes from airway epithelial cells, as described previously by
our laboratory and originally described by Barile et al [22–24]. In
brief, CFBE cells with or without SGK1 knockdown, by siSGK1,
were scraped from filters into isolation buffer (10 mM triethanol-
amine, 250 mM sucrose, pH to 7.6, 8 mg/liter PMSF and
0.08 mg/liter leupeptin). Cells were homogenized with plastic
tube homogenizer and centrifuged at 40006g for 10 minutes at
4uC. Supernatant was saved, homogenization repeated on the
pellet. Pooled supernatants were centrifuged at 170006g for 20
minutes at 4uC, then supernatant centrifuged at 200,0006g for
one hour at 4uC. The pellet was resuspended via homogenization
and centrifuged a second time for one hour at 200,0006g at 4uC.
The pellet was resuspended in PBS containing protease inhibitors
and wt-CFTR was immunprecipitated from this fraction (intra-
cellular vesicle fraction). Control experiments were performed with
a non-specific antibody (IgG). Immunoprecipitated proteins,
including wt-CFTR and proteins associated with wt-CFTR-
Figure 2. Dexamethasone increased SGK1 protein abundance in a time-dependent manner. (A) Western blot demonstrating that the
Sigma SGK1 antibody recognizes SGK1. CFBE cells were transfected with cDNA (0, no SGK1 insert), or SGK1 cDNA (0.2, 0.4, 0.6, 0.8 and 1.0 mg) and 48
hours later cells were lysed and SGK1 and ezrin were analyzed by Western blot. The SGK1 antibody recognized a protein (,48 kDa, the predicted
molecular mass of SGK1) that increases in intensity as the amount of SGK1 cDNA transfected into CFBE cells was increased. By contrast, the intensity
of a non-specific protein (.50 kDa, marked by a # sign in Figure 2A), did not change as a function of the amount of SGK1 cDNA transfected in CFBE
cells. (B) Representative western blot of an experiment in which CFBE cells were treated with dexamethasone (50 nM) for the indicated times at 37uC.
Subsequently, cells were lysed and SGK1 and ezrin were analyzed by western blot. Data expressed as a percent of the maximum SGK1 levels observed
at 4 hours (100%). Ezrin was monitored as a loading control (each lane was loaded with 50 mg of protein). # indicates a non-specific protein detected
by the SGK1 antibody. The black box highlights SGK1 protein, which is also indicated by an *. (C) Summary of three experiments. Data expressed as
SGK1 normalized for the amount of ezrin. *p,0.05 vs. 0 time point (no dexamethasone treatment: cells were treated with vehicle).
doi:10.1371/journal.pone.0089599.g002
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containing vesicles, were run on an SDS PAGE gel whereupon
western blots were performed using antibodies to either Rab 5a (to
determine the amount of wt-CFTR in early endosomes), EEA1 (to
determine the amount of wt-CFTR in early endosomes), and Rab
11a (to determine the amount of wt-CFTR in recycling
endosomes).
RNA Isolation and Quantitative-Reverse Transcription-
PCR
Quantitative-Reverse transcription (Q-RT-PCR) studies were
conducted to examine the effect of dexamethasone (50 nM) on the
expression of SGK1 mRNA in CFBE cells, as previously described
in detail [16]. In brief, total RNA was isolated from cells treated
with vehicle (0.01% ethanol in PBS, i.e., control) or dexameth-
asone using the RNAeasy Mini Kit (Qiagen, Valencia, CA). RNA
was treated with DNase (DNA-Free, Ambion, Austin, TX) to
remove contaminating DNA. Total RNA was quantified using
spectrophotometric OD260/280 measurements (NanoDrop, Na-
noDrop Technologies, Rockland, DE) and RNA quality was
assessed with an Agilent 2100 Bioanalyzer (Agilent Technologies,
Wilmington, DE). A Taqman Gene Expression assay was used for
Q-RT-PCR for human SGK1 (Applied Biosystems, Foster City,
CA catalog # 4331182). Q-RT-PCR products were run on a low
melting point agarose gel to confirm amplicon size, subcloned into
pCR4-TOPO (Invitrogen), and submitted for sequence analysis to
confirm the identity of the product.
Antibodies and Reagents
The antibodies used were: rabbit anti-SGK1 antibody (Sigma);
mouse anti-CFTR C-terminus antibody (clone 24-1; R&D
systems, Minneapolis, MN); mouse anti-CFTR antibody (clone
596; University of North Carolina Cystic Fibrosis Center, Chapel
Hill, NC); mouse anti-ezrin, mouse anti-Rab5a and mouse anti-
EEA1 antibodies (BD Biosciences, San Jose, CA); rabbit anti-Rab
11a (Life Technologies Corp); mouse anti-EGFR (Santa Cruz
Biotechnology, Inc, Santa Cruz, CA); horseradish peroxidase-
conjugated goat anti-mouse and goat anti-rabbit secondary
antibodies (Bio-Rad, Hercules, CA). SGK1-S442D, a constitu-
tively active form of human SGK1 and human SGK1-K127N, an
inactive form of human SGK1, were constructed as described
[15]. The SGK inhibitor GSK 650394 was obtained from Tocris
(purchased through R&D Systems, Minneapolis, MN). All
antibodies and reagents were used at the concentrations recom-
mended by the manufacturers.
Data Analysis and Statistics
Graphpad Prism version 5.0 for Macintosh (Graphpad, San
Diego, CA) was used to perform a statistical analysis of the data.
Means were compared using a t-test or ANOVA followed by
Tukeys test, as appropriate. P,0.05 was significant, and all data
are expressed as the mean 6 SEM.
Figure 3. Dexamethasone increased wt-CFTR abundance in cell lysates (A), and in the apical membrane (B). Representative western
blots and data summaries are presented. (A) Cells were treated with dexamethasone (50 nM) for the indicated times at 37uC and western blot analysis
was conducted to measure wt-CFTR and ezrin in cell lysates. The molecular mass of wt-CFTR is ,180 kDa. Ezrin was monitored as a loading control.
n = 7 per time point. *p,0.05 versus 0 time point. (B) Cells were treated with dexamethasone (50 nM) for the indicated time points at 37uC, and
subsequently apical plasma membrane proteins were biotinylated using a technique previously described in detail by our laboratory [12,22]. Briefly,
apical membrane proteins were biotinylated at 4uC using EZ-LinkTM Sulfo-NHS-SS-Biotin. Subsequently, cells were lysed, and the biotinylated proteins
were isolated by streptavidin-agarose beads, eluted into SDS sample buffer, and separated by 7.5% SDS-PAGE. The blots were probed for wt-CFTR
(,180 kDa) and for ezrin, a cytoplasmic protein that was not present in the biotinylated samples, confirming that biotin is impermeable to cell
membranes [12,22], and that the procedure to determine apical membrane wt-CFTR does not detect intracellular wt-CFTR. In this and all subsequent
biotinylation experiments ezrin was never detected in the biotinylated samples by western blot, demonstrating that only plasma membrane proteins
were biotinylated. *p,0.05 versus 0 time point. **p,0.01 versus 0 time point.
doi:10.1371/journal.pone.0089599.g003
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Results
Dexamethasone Increases SGK1 mRNA and Protein
Abundance
Stress and glucocorticoids are well known stimuli of SGK1 gene
expression [13]. To determine if dexamethasone increases SGK1
expression in human airway epithelial cells, CFBE cells were
treated with vehicle (control) or dexamethasone (50 nM for 30
minutes) and SGK1 mRNA was measured by Q-RT-PCR.
Dexamethasone significantly increased SGK1 mRNA compared
to control (Figure 1). To determine if dexamethasone also
increased SGK1 protein abundance we conducted western blot
analysis of CFBE cells treated with dexamethasone or vehicle.
First, we conducted a western blot analysis of CFBE cells
transfected with several concentrations of SGK1 cDNA to verify
that the SGK1 antibody recognizes human SGK1. Figure 2A
reveals that the SGK1 antibody recognizes a protein (,48 kDa,
the molecular mass of SGK1) that increases in intensity as the
amount of SGK1 cDNA transfected into CFBE cells was
increased. By contrast, the intensity of a non-specific protein (.
50 kDa, marked by a # sign in Figure 2A) did not change as a
function of the amount of SGK1 cDNA transfected. Using the
SGK1 antibody we observed that dexamethasone rapidly, and
significantly, increased SGK1 protein abundance (Figures 2B and
2C). Although SGK1 levels were low in control cells, an increase
in SGK1 protein was observed after 1 hour, peaked 4 hours after
dexamethasone exposure and remained elevated for the duration
of the experiment compared to vehicle treated CFBE cells
(time= 0, Figures 2B and 2C).
Dexamethasone Increases Plasma Membrane wt-CFTR
We also examined the effect of dexamethasone on wt-CFTR
abundance in cell lysates, as well as in the apical membrane using
cell-surface protein biotinylation and Western blot analysis.
Dexamethasone rapidly, and significantly, increased wt-CFTR
abundance in the cell lysate (Figure 3A) and in the apical plasma
membrane (Figure 3B). The increase in apical plasma membrane
wt-CFTR was significantly increased one hour after dexametha-
sone exposure and persisted for the duration of the experiment (24
hours).
SGK1 Increases Apical Membrane wt-CFTR Abundance
To test the hypothesis that dexamethasone increases apical
membrane wt-CFTR by increasing SGK1 activity, we used an
inhibitor of SGK1 kinase activity in the presence of dexameth-
asone. Inhibition of SGK1 kinase activity by GSK 650394
abrogated the dexamethasone induced increase in apical plasma
membrane wt-CFTR, as measured by cell surface protein
biotinylation and western blot analysis (Figures 4A and 4B).
GSK 650394, in cells not treated with dexamethasone, had no
significant effect on plasma membrane wt-CFTR (Figures 4A and
4B). To provide additional support for the observation that the
dexamethasone induced increase in plasma membrane wt-CFTR
is mediated by SGK1, cells were transfected with either siSGK1 or
siNeg, and then the cells were treated with dexamethasone and
apical membrane wt-CFTR was measured by biotinylating apical
plasma membrane proteins followed by western blot analysis.
Compared to siNeg, siSGK1 significantly reduced the dexameth-
asone induced increase in SGK1 protein abundance (Figures 5A
and 5B), an effect that reduced the dexamethasone induced
increase in apical plasma membrane wt-CFTR (Figures 5C and
5D). To provide additional support for the conclusion that SGK1
increases plasma membrane wt-CFTR, cells were transfected with
plasmid (mock), SGK1-S422D, a constitutively active SGK1, or an
inactive SGK1 (SGK1-K127N) to serve as an additional control,
all in the absence of dexamethasone. Compared to mock
transfected cells or cells transfected with SGK1-K127N, SGK1-
422D significantly increased plasma membrane wt-CFTR
(Figures 5E and 5F). Taken together the experiments in Figures 4
and 5 support the conclusion that activation of SGK1 increases the
apical plasma membrane abundance of wt-CFTR in human
airway epithelial cells.
SGK1 Inhibits the Endocytic Retrieval of wt-CFTR from
the Apical Plasma Membrane
Although others and we have demonstrated that SGK1
increases the plasma membrane abundance of wt-CFTR in a
variety of cell types, the mechanism of this effect has not been
elucidated. To determine if SGK1 regulates the apical membrane
trafficking of wt-CFTR, studies were conducted to test the novel
hypothesis that SGK1 increases apical plasma membrane wt-
CFTR by inhibiting its endocytic retrieval and/or enhancing its
recycling from endosomes back to the membrane. In dexameth-
asone treated cells siSGK1, which decreased SGK1 protein levels
Figure 4. The SGK inhibitor GSK 650394 blocked the dexa-
methasone stimulated increase in apical membrane wt-CFTR.
(A) Representative western blot, and (B) Data quantitation. CFBE cells
were treated with either vehicle, GSK 650394 (100 nM), an inhibitor of
SGK1, dexamethasone (50 nM), or dexamethasone (50 nM), and GSK
650394 (100 nM) for 24 hours at 37uC. The molecular mass of apical
plasma membrane wt-CFTR is ,180 kDa. Experiments performed four
times. *p,0.05 versus vehicle. **p,0.05 versus dexamethasone.
doi:10.1371/journal.pone.0089599.g004
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by ,75% (Figures 6A and 6B) increased wt-CFTR endocytosis
compared to cells transfected with siNeg (Figures 6A and 6B). By
contrast, transfection of cells, not exposed to dexamethasone, with
SGK1-S442D reduced wt-CFTR endocytosis compared to endo-
cytosis of wt-CFTR in cells transfected with SGK1-K127N
(Figures 6C and 6D). These experiments are consistent with the
conclusion that increasing SGK1 inhibits the endocytic retrieval of
wt-CFTR from the plasma membrane, which increases apical
plasma membrane wt-CFTR.
SGK1 does not Affect the Endocytic Recycling of wt-CFTR
from Endosomes to the Apical Plasma Membrane
Figure 7 demonstrates that SGK1 does not regulate the
recycling of endocytosed wt-CFTR back to the plasma membrane.
In dexamethasone treated cells siSGK1, which reduced SGK1
protein levels by ,75% (Figures 5A and 5B) had no effect on the
endocytic recycling of wt-CFTR compared to cells transfected
with siNeg (Figures 7A and 7B). Moreover, transfection of cells,
not exposed to dexamethasone, with SGK1-S442D also had no
effect on the endocytic recycling of wt-CFTR compared to cells
transfected with SGK1-K127N (Figures 7C and 7D).
Finally, we examined the effect of siSGK1 on the subcellular
location of wt-CFTR to provide additional support for the
conclusion that SGK1 inhibits wt-CFTR endocytosis, but does
not alter wt-CFTR recycling. To this end, cells were transfected
with siNeg or siSGK1, intracellular vesicles were isolated
whereupon wt-CFTR was immunoprecipitated, and the immu-
noprecipitated proteins were run on an SDS PAGE gel. Western
blots were then performed using EEA1 and Rab5a to quantitate
the amount of wt-CFTR in early endosomes, and with Rab11a, to
quantitate the amount of wt-CFTR in recycling endosomes.
Figures 8A and 8B demonstrate that siSGK1 increased the
amount of wt-CFTR in early endosomes (i.e., the amount of co-
immunoprecipitation between wt-CFTR with EEA1 and Rab5a
was increased), an observation consistent with the endocytic assays
demonstrating that SGK1 inhibits the endocytic removal of wt-
CFTR from the apical plasma membrane into early endosomes.
By contrast, siSGK1 had no effect on the amount of wt-CFTR in
recycling endosomes (i.e., the amount of co-immunoprecipitation
between wt-CFTR with Rab11a was unchanged), an observation
consistent with the endocytic recycling assay demonstrating that
SGK1 has no effect on the endocytic recycling of wt-CFTR from
endosomal vesicles back to the apical plasma membrane. Taken
together these experiments support the conclusion that SGK1
inhibits the endocytic retrieval of wt-CFTR from the plasma
membrane, but has no effect on wt-CFTR endocytic recycling.
SGK1 Stimulates the Endocytosis of the Epidermal
Growth Factor Receptor (EGFR)
The EGFR is an apical plasma membrane protein that, like wt-
CFTR, is endocytosed from the apical plasma membrane of
polarized epithelial cells in clathrin-coated vesicles [25,26]. To
determine if SGK1 selectively inhibited the endocytosis of wt-
CFTR, or had a non-specific effect on other apical plasma
membrane proteins, studies were conducted to determine if SGK1
regulates the endocytosis of the EGFR. Accordingly, polarized
CFBE cells were transfected with SGK1-S422D or SGK1-K127N,
and EGFR endocytosis were measured, as described in Methods.
Figure 9 demonstrates that SGK1-S422D, the constitutively active
form of SGK1, significantly enhanced the endocytosis of EGFR
(Figures 9A and 9B) from the apical plasma membrane compared
to SGK1-K127N, the inactive form of SGK1, which served as the
control. This observation, taken together with studies presented
above, demonstrates that SGK1 differentially regulates the
endocytosis of wt-CFTR (inhibits) and the EGFR (stimulates).
Figure 5. siSGK regulates apical plasma membrane wt-CFTR abundance. Representative western blots and data summaries are presented.
(A) and (B), siSGK1 reduced SGK1 protein abundance in cells treated with dexamethasone. CFBE cells were transfected with siNeg or siSGK1, and 24
hours later treated with dexamethasone (50 nM) for 4 hours, whereupon SGK1 levels in cell lysates were measured by western blot analysis. (C) and
(D), siSGK1 reduced wt-CFTR protein abundance in the apical membrane of cells treated with dexamethasone. CFBE cells were transfected with siNeg
or siSGK1, and 24 hours later treated with dexamethasone (50 nM) for 4 hours, whereupon wt-CFTR levels in the apical plasma membrane were
measured by plasma membrane protein biotinylation followed by western blot analysis as described in Methods. For A-D experiments performed
three times. *p,0.05 versus siNeg. E and F. Constitutively active SGK1 (SGK1-S422D) increased apical membrane wt-CFTR, whereas a dominant
negative, kinase inactive SGK1 (SGK1-K127N) had no effect on apical membrane wt-CFTR compared to mock (vector control). CFBE cells were
transfected with either SGK1-S422D, SGK1-K127N, or vector control (mock). Ezrin was a loading control. Plasma membrane wt-CFTR was determined
by biotinylation of apical membrane proteins as described in Methods. Experiments performed six times. *p,0.05 as indicated.
doi:10.1371/journal.pone.0089599.g005
SGK1 Reduces CFTR Endocytosis
PLOS ONE | www.plosone.org 6 February 2014 | Volume 9 | Issue 2 | e89599
Discussion
The results of this study demonstrate for the first time that
SGK1 increases the abundance of wt-CFTR in the apical plasma
membrane of human airway epithelial cells by selectively
inhibiting the endocytic retrieval of wt-CFTR from the plasma
membrane. SGK1 also increases the amount of wt-CFTR in the
plasma membrane of Xenopus oocytes [14,15] and in mitochon-
drion rich cells in the gill of the killifish (Fundulus heteroclitus) [16,17].
In a recent study Caohuy et al [18] showed that dexamethasone
increases the plasma membrane expression of both wt-CFTR and
DF508-CFTR in pancreatic cells, and that RNA interference of
SGK1 blocked the stimulatory effect of dexamethasone on plasma
membrane DF508-CFTR. Moreover, Rubenstein et al [19]
reported that dexamethasone also increases wt-CFTR and
DF508-CFTR abundance in CFBE41o- cells, and Prota et al
[20] showed in Calu-3 cells that dexamethasone increases wt-
CFTR biosynthesis by altering its interaction with the chaperones
HSP70 and HSP90 present in the endoplasmic reticulum. The
present study extends these observations and demonstrates, for the
first time, that SGK1 increases plasma membrane wt-CFTR in
polarized airway epithelial cells by selectively inhibiting the
endocytic retrieval of wt-CFTR from the apical plasma mem-
brane. By contrast, SGK1-S422D stimulated the endocytic
retrieval of the EGRF from the apical plasma membrane.
Figure 6. SGK1 inhibits wt-CFTR endocytosis. (A) and (B), siRNA-mediated knockdown of SGK1 in cells treated with dexamethasone (50 nM for
4 hours) enhanced the endocytic removal of wt-CFTR from the apical membrane. CFBE cells were transfected with siSGK1 or a scrambled negative
control (siNeg) and 24 hours later treated with dexamethasone (50 nM) for 4 hours. (A) Representative western blot and (B) summary of data. Wt-
CFTR endocytosis was measured by a method described previously in detail and in Methods [12,22]. In brief, in three sets of cells apical membrane
proteins were biotinylated at 4uC using EZ-LinkTM Sulfo-NHS-SS-Biotin. Subsequently, one set of cells (lane 1) were then lysed, and the biotinylated
proteins were isolated by streptavidin-agarose beads, eluted into SDS sample buffer, separated by 7.5% SDS-PAGE, and probed for wt-CFTR and ezrin.
Thus, lane 1 represents the amount of wt-CFTR in the apical membrane at time= 0. A second set of cells (lane 3) were also biotinylated at 4uC and
then warmed to 37uC for 5 min to allow biotinylated wt-CFTR to be endocytosed. Subsequently, the cells were cooled to 4uC, and the disulfide bonds
on Sulfo-NHS-SS-biotinylated proteins remaining in the apical membrane were reduced by GSH added to the apical solution for a total of 90 min at
4uC. The cells were then lysed, and the biotinylated proteins were isolated by streptavidin-agarose beads, eluted into SDS sample buffer, separated by
7.5% SDS-PAGE, and probed for wt-CFTR and ezrin. Thus, lane 3 represent the amount of wt-CFTR in the apical membrane at time= 0 that was
endocytosed in 5 minutes. Lane 2 demonstrates that GSH reduced the disulfide bonds on Sulfo-NHS-SS-biotinylated proteins in the apical membrane.
Cells in this lane were biotinylated at 4uC and the disulfide bonds on Sulfo-NHS-SS-biotinylated proteins remaining in the apical membrane were
reduced by GSH added to the apical solution for a total of 90 min at 4uC. The amount of biotinylated wt-CFTR remaining in the plasma membrane
after GSH treatment at 4uC and without the 37uC warming was considered background (,5% compared with the amount of biotinylated wt-CFTR at
4uC without GSH treatment, i.e., lane 1) and was subtracted from the wt-CFTR biotinylated after warming to 37uC at each time point. wt-CFTR
endocytosis is reported as the amount of CFTR in lane 3 (minus background) divided by the amount in lane 1 (minus background) X 100.
Quantification of three experiments. *p,0.05 versus siNeg (control). (C) and (D), Constitutively active SGK (SGK1-S422D) reduced the endocytic rate of
wt-CFTR from the apical membrane compared to a dominant negative SGK1 (K127N). CFBE cells were transfected with SGK1-S422D or SGK1-K127N
and wt-CFTR endocytosis was measured as described above. Representative western blot (C), and summary of the data (D). Quantification of three-six
experiments. *p,0.05 versus K127N.
doi:10.1371/journal.pone.0089599.g006
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Five lines of evidence in the present study support the
conclusion that SGK1 selectively increases apical plasma mem-
brane wt-CFTR in polarized human airway epithelial cells by
inhibiting its endocytic retrieval from the membrane. First,
siSGK1 increased the rate of wt-CFTR endocytosis from the
plasma membrane. Second, constitutively active SGK1-S442D
decreased the rate of wt-CFTR endocytosis from the membrane.
Third, co-immunoprecipitation studies with markers of intracel-
lular compartments revealed that siSGK1 increases the amount of
wt-CFTR in early endosomes, but not in recycling endosomes.
Fourth, neither siSGK1 nor SGK1-S442D altered the rate of wt-
CFTR recycling or the amount of wt-CFTR in recycling
endosomes. Fifth, SGK1-S422D increased the endocytosis of the
EGFR. Thus, taken together our studies revealed for the first time
in polarized airway epithelial cells that SGK1 selectively increased
apical plasma membrane wt-CFTR by inhibiting its endocytic
removal from the membrane.
SGK1 also regulates the plasma membrane abundance of a
number of other ion channels and transport proteins including
ROMK, ENaC, and Kv7.1, to name but a few, by regulating their
endocytic removal from the plasma membrane [5,13,27]. For
example, SGK1 reduces the plasma membrane abundance of
ROMK, a potassium channel in the kidney, by phosphorylating
WNK1, which increases the endocytic retrieval of ROMK from
the plasma membrane [28]. By contrast, SGK1 increases the
membrane expression of ENaC, the epithelial sodium channel,
and therefore stimulates sodium reabsorption in the kidney, by
phosphorylating and inhibiting Nedd4-2, an E3 ubiquitin ligase,
thereby reducing the amount of ubiquitinated ENaC and
inhibiting ENaC endocytosis [29]. SGK1 also increases the
plasma membrane abundance of Kv7.1, a voltage gated potassium
channel, by phosphorylating and inhibiting Nedd4-2-dependent
endocytosis of Kv7.1 [27]. Therefore, the kinase activity of SGK1
plays a critical role in the mechanism by which SGK regulates the
endocytic trafficking of other membrane proteins.
Figure 7. SGK1 did not alter the recycling of endocytosed wt-CFTR from endosomes back to the apical membrane. siRNA-mediated
knockdown of SGK1. (A) Representative western blot, and (B) summary of the data. The recycling assay has been described in detail previously and in
Methods [12,22]. In brief, the first three lanes in A are similar to those described in Figure 6 for the endocytosis experiments. Thus, lane 1 represents
the amount of wt-CFTR in the plasma membrane at time= 0, lane 3 represents the amount of wt-CFTR endocytosed in 5 minutes and lane 2 shows
that GSH cleaves the disulfide bonds on Sulfo-NHS-SS-biotinylated wt-CFTR in the apical membrane. In lane 4 cells were warmed to 37uC for 5 min
after biotinylation to load endocytic vesicles with biotinylated proteins. Cells were then cooled to 4uC, and the disulfide bonds on Sulfo-NHS-SS-
Biotin-labeled proteins remaining in the plasma membrane were reduced by GSH at 4uC. Subsequently, cells were warmed again to 37uC for 5 min to
allow endocytosed and biotinylated wt-CFTR to recycle to the plasma membrane. Cells were then cooled again to 4uC, and the disulfide bonds on
biotinylated proteins in the apical membrane were reduced with GSH. The amount of recycled wt-CFTR was calculated as the difference between the
amount of biotinylated wt-CFTR after the first and second GSH treatments (minus background)6100. Experiments repeated four-five times. NS, not
significant. (C) and (D), The constitutively active SGK1 (SGK1-S422D) does not alter the recycling of wt-CFTR to the apical membrane. (C)
Representative western blot, and (D) Summary of the data. The recycling assay was performed as described above. Experiments repeated four-five
times. NS, not significant.
doi:10.1371/journal.pone.0089599.g007
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The mechanism whereby SGK1 regulates the endocytosis of wt-
CFTR is not known. Caohuy et al [18] demonstrated that
activation of SGK1 in pancreatic cells increased membrane
DF508-CFTR by blocking Nedd4-2-mediated ubiquitination of
DF508-CFTR, which reduces DF508-CFTR plasma membrane
stability. However, in a recent study we reported that Nedd4-2
does not regulate the membrane abundance of wt-CFTR in
human airway epithelial cells [30]. It is unclear if the difference in
the results of these studies is due to different effects of SGK1 on
wt-CFTR versus DF508-CFTR and/or to differences in pancre-
atic cells versus airway cells. Interestingly, in a recent study [19] it
was shown that dexamethasone increases DF508-CFTR abun-
dance in CFBE41o- cells, but did not increase the fully
glycosylated, so-called C band of DF508-CFTR-the form that
traffics to the plasma membrane, an observation consistent with
the conclusion that there is an inherent difference in the effects of
dexamethasone (and SGK1) on plasma membrane DF508-CFTR
in airway cells and in pancreatic epithelial cells. Because wt-CFTR
does not contain a SGK1 phosphorylation consensus sequence it is
unlikely that SGK1 inhibits CFTR endocytosis in airway epithelial
cells by directly phosphorylating wt-CFTR. However, it is possible
that SGK1 may phosphorylate one or more of the many proteins
that regulate wt-CFTR endocytosis, including, for example, c-Cbl,
Dab2, Rab5, myosin VI, AP2, dynamin, and NHERF1, which
Figure 8. siSGK1 increased the amount of wt-CFTR in early endosomes, but not in recycling endosomes. Co-immunoprecipitation
studies were conducted to determine the subcellular location of wt-CFTR in siNeg and siSGK1 transfected cells treated with dexamethasone (50 nM
for 4 hours). EEA and Rab5a are markers of early endosomes, and Rab11a is a marker of recycling endosomes. wt-CFTR was immunoprecipitated, and
co-immunoprecipitated proteins were eluted into SDS sample buffer, and separated by 7.5% SDS-PAGE. The blots were then probed for wt-CFTR,
EEA, Rab5a, and Rab11. Co-immunoprecipitation of wt-CFTR with EEA1 and Rab5a identifies the amount of wt-CFTR in early endosomes, and co-
immunoprecipitation of wt-CFTR with Rab11a identifies the amount of wt-CFTR in recycling endosomes. Quantification of data for Rab and EEA1
immunoprecipitation with wt-CFTR in siNeg and siSGK1 cells is normalized for the total amount of wt-CFTR immunoprecipitated. Blots in siNeg and
siSGK1 experiments were cut for presentation, but were run one the same blot to allow for comparison. Lysate, the amount of EEA1, Rab5a Rab11
and wt-CFTR in cell lysates. CFTR IP, indicates IP with the anti-CFTR antibody and then western blot with the indicated antibody. IgG,
immunoprecipitation with a non-specific antibody. (A) Representative western blots and (B) Summary of the data. Experiments repeated three times.
*P,0.05 versus siNeg.
doi:10.1371/journal.pone.0089599.g008
Figure 9. SGK1 stimulates EGFR endocytosis. (A) and (B), Constitutively active SGK1 (S422D) increased the endocytic rate of EGFR from the
apical membrane compared to a dominant negative SGK1 (K127N). CFBE cells were transfected with SGK1-S422D or SGK1-K127N and EGFR
endocytosis was measured as described in detail in Methods and in Figure legends above. Representative western blot (A), and summary of the data
(B). Quantification of three experiments. *P,0.05 versus K127N.
doi:10.1371/journal.pone.0089599.g009
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interacts with the ezrin/radix/moesin (ERM) family of proteins
that anchors wt-CFTR to the apical membrane by interacting with
the apical actin cytoskeleton [8,31–35]. In addition, SGK1 may
phosphorylate a protein that may affect the membrane stability of
wt-CFTR. For example, Shank2E, via its PDZ domain, binds to
the C-terminus of wt-CFTR and increases plasma membrane wt-
CFTR [36,37]. Inspection of the amino acid sequence of Shank2E
reveals two SGK1 consensus phosphorylation sites. Because
Shank2E interacts with dynamin, a GTPase that regulates synaptic
vesicle recycling, and receptor-mediated endocytosis [38], it is
possible that SGK1 may phosphorylate Shank2E and inhibit wt-
CFTR endocytosis. Additional studies are required to elucidate
how SGK1 selectively inhibits wt-CFTR endocytosis in airway
epithelial cells. Given the number of possible targets of SGK1 such
an analysis will likely be a major challenge.
In this manuscript we demonstrate differential regulation of the
endocytosis of additional cell surface proteins, including EGFR by
SGK1. SGK1 has inverse actions on wt-CFTR and EGFR,
decreasing and increasing endocytosis, respectively. To gain
insight into the differential regulation by SGK1, we considered
the protein-protein interactions and intracellular itineraries of wt-
CFTR and EGFR. While both proteins undergo clathrin-
mediated endocytosis, the protein-protein interactions and intra-
cellular trafficking itineraries of each of these proteins are quite
distinct [1,39]. Amino acid sequence examination also reveals that
neither wt-CFTR nor EGFR contain SGK1 consensus phosphor-
ylation sequences. Thus, it is likely that SGK1 kinase activity is
required for phosphorylation and regulation of proteins that in
turn regulate the endocytosis of wt-CFTR and EGFR. For
example, in human proximal kidney tubule cells, SGK1 overex-
pression has been demonstrated to increase the tyrosine phos-
phorylation of EGFR, an action previously demonstrated to
increase endocytosis [40,41]. In addition, SGK1-mediated activa-
tion of PIKfyve kinase leads to increased wt-CFTR channel
activity and plasma membrane abundance [42]. As stated above,
additional studies are required to elucidate the differential
regulation of endocytic trafficking of cell plasma membrane
proteins by SGK1.
Low doses of dexamethasone slow the progression of CF by
reducing inflammation caused by chronic bacterial infection [43].
Because dexamethasone also increases the biosynthesis of wt-
CFTR [20] as well as the plasma membrane expression of wt-
CFTR [18,20](present study), the use of dexamethasone in CF
patients receiving VX-770 [44], which activates G551D-CFTR in
the plasma membrane, and VX-809 [45], which increases the
amount of DF508-CFTR in the plasma membrane, should be
considered to enhance the efficacy of VX-770 and VX-809.
Conclusion
In conclusion, our data provide the first direct evidence that, in
polarized human airway epithelial cells, the glucocorticoid-
induced increase in SGK1 protein abundance and activity
enhances the plasma membrane abundance of wt-CFTR by
inhibiting its endocytic retrieval from the plasma membrane.
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